Accuray (ARAY) Competitors

Orthofix Medical (NASDAQ:OFIX) and Accuray (NASDAQ:ARAY) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, profitability, earnings, dividends, valuation, media sentiment, analyst recommendations and institutional ownership.

Do insiders and institutionals have more ownership in OFIX or ARAY?

89.8% of Orthofix Medical shares are owned by institutional investors. Comparatively, 64.1% of Accuray shares are owned by institutional investors. 1.3% of Orthofix Medical shares are owned by insiders. Comparatively, 4.2% of Accuray shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Which has stronger valuation and earnings, OFIX or ARAY?

Accuray has lower revenue, but higher earnings than Orthofix Medical. Accuray is trading at a lower price-to-earnings ratio than Orthofix Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Orthofix Medical	$799.49M	0.72	-$126M	-$3.17	-4.59
Accuray	$458.51M	0.39	-$1.59M	-$0.02	-79.50

Does the media prefer OFIX or ARAY?

In the previous week, Accuray had 14 more articles in the media than Orthofix Medical. MarketBeat recorded 15 mentions for Accuray and 1 mentions for Orthofix Medical. Orthofix Medical's average media sentiment score of 0.88 beat Accuray's score of -0.01 indicating that Orthofix Medical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Orthofix Medical	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Accuray	2 Very Positive mention(s)	0 Positive mention(s)	5 Neutral mention(s)	1 Negative mention(s)	2 Very Negative mention(s)	Neutral

Which has more volatility and risk, OFIX or ARAY?

Orthofix Medical has a beta of 0.82, indicating that its share price is 18% less volatile than the S&P 500. Comparatively, Accuray has a beta of 1.24, indicating that its share price is 24% more volatile than the S&P 500.

Do analysts prefer OFIX or ARAY?

Orthofix Medical presently has a consensus price target of $21.50, indicating a potential upside of 47.77%. Accuray has a consensus price target of $5.00, indicating a potential upside of 214.47%. Given Accuray's higher possible upside, analysts plainly believe Accuray is more favorable than Orthofix Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Orthofix Medical	0 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	3.00
Accuray	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

Is OFIX or ARAY more profitable?

Accuray has a net margin of -0.35% compared to Orthofix Medical's net margin of -15.29%. Accuray's return on equity of -5.79% beat Orthofix Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Orthofix Medical	-15.29%	-25.43%	-14.46%
Accuray	-0.35%	-5.79%	-0.58%

Summary

Accuray beats Orthofix Medical on 9 of the 16 factors compared between the two stocks.